Applied Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
APLT on Nasdaq
Industry
Pharmaceutical Preparations
Location
545 Fifth Avenue, Suite 1400, New York, NY

Insiders trading volume in the past year

Applied Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shoshana Shendelman President and CEO, Director $32.3M -$4.98M -13.4% Aug 5, 2024
Alexandria Real Estate Equities, Inc. 10%+ Owner $26.3M -$1.27M -4.59% Jun 4, 2024
Adam Hansard Chief Commercial Officer $3.95M Mar 14, 2024
John Johnson Executive Chairman, Director $2.92M Dec 19, 2024
Joel S. Marcus Director $2.11M Jun 6, 2024
Stacy J. Kanter Director $458K Jun 6, 2024
Teena Lerner Director $447K Jun 6, 2024
Charles Silberstein Chief Financial Officer $400K Jan 7, 2022
Riccardo Perfetti Chief Medical Officer $392K -$284K -42.1% Mar 4, 2025
Leslie D. Funtleyder Interim Chief Executive Officer and Chief Financial Officer, Director $326K -$173K -34.6% Mar 24, 2025
Jay S. Skyler Director $276K Jun 6, 2024
Constantine Chinoporos Chief Operating Officer and Chief Business Officer $273K -$17.3K -5.97% Mar 24, 2025
Corwin Dale Hooks Chief Commercial Officer $242K Mar 24, 2025
Steven A. Ortega Principal Accounting Officer $121K Nov 15, 2022
Chids Mahadevan Title: Senior Vice President of Finance (Interim Principal Financial Officer) $21.4K Aug 2, 2022
Catherine Thorpe Chief Accounting Officer Jun 16, 2023

Recent Insider Transactions by Companies or Individuals for Applied Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.